Life-Sciences-Asia.com
The East-West Life Sciences Web Portal

This is a free web portal for the life sciences in Asia-Pacific, Europe and North America... » read more

AstraZeneca to Invest $2.5b in Beijing (2025-03-21)
> AstraZeneca is establishing a new global strategic R&D centre in Beijing, its second in China and sixth worldwide > Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai AstraZeneca today announced an investment of $2.5 bi...
[iito] Announces Major Changes in Its Social Media Strategy (2025-03-18)
> [iito] ceased all activities on Twitter/X in 2023 > All social media activities today focussed on LinkedIn > Planning for a future outside of the “big” social media platforms [iito] Business Intelligence – a Germany-based business intelligence p...
RegCell Secures $45.8m in Funding; Moves HQ to US (2025-03-18)
> Funding includes $8.5M from an oversubscribed seed financing with up to $37.3M in non-dilutive investment from The Japan Agency for Medical Research and Development (AMED), underscoring Japan’s commitment to breakthrough therapies > Funding will advance RegC...
AstraZeneca Licenses Drug Delivery Technology from Alteogen (2025-03-17)
AstraZeneca and Alteogen Inc. have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase utilising Hybrozyme™ platform technology. Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and com...
Taiho to Acquire Araris Biotech AG for up to $1.14b (2025-03-17)
Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho Pharmaceutical") and Araris Biotech AG (hereinafter "Araris"), a Swiss biotechnology company developing next-generation antibody drug conjugates (ADCs), announced today that they have entered into a definitive agre...
Insilico Medicine’s $110m Series E Led by Value Partners (2025-03-13)
Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced today that it has successfully secured a $110 million Series E financing led by a private equity fund of Value Partners Group (HKG:0806...
Samsung Invests $10m in C2N Diagnostics (2025-03-13)
C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a $10 million USD investment from Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment Corp...
Valo Therapeutics Raises €19m Investment Round (2025-03-10)
Valo Therapeutics Oy announces that it has successfully secured a financing round of €19 million, part of which was raised in Europe and part in Australia, to clinically develop its innovative immune therapy for cancer. An investment round of €13 million wa...
Sun Pharma to Acquire Checkpoint Therapeutics (2025-03-10)
> Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma’s global onco-derm franchise > Will leverage Sun Pharma’s global presenc...
Trimtech Therapeutics Raises £25m Seed Round for TPD (2025-03-05)
> Oversubscribed financing led by Cambridge Innovation Capital and SV Health Investors’ Dementia Discovery Fund with M Ventures and Pfizer Ventures joining > Investment will support further development of CNS penetrant therapeutics based on the Company’s TRI...

Life-Sciences-Asia.com is your doorway to the East-West life sciences!

[LSA] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Asia-Pacific, Europe and North America regions.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSA] is 100% Made in Europe!

» Start here with the latest News!

Picture Swiss Biotech Association LSA Swiss Biotech Days 2025 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]